FDA shames firms fighting generic competitors

Share
FDA shames firms fighting generic competitors

The Food and Drug Administration (FDA) is taking what, for an agency that's generally known for its caution and under-the-radar regulatory approach, may be seen as an aggressive new tact against drug makers: Publicly calling out companies accused of delaying the entry of cheaper generic drugs to the market by preventing generic manufacturers from getting samples of expensive brand name medicines. On Thursday it posted a list of more than 50 drugs for which it says drugmakers reportedly refused to give generic drugmakers samples they need to develop copies that will eventually cut consumer prices.

"This is a great day for for patients, since the administration's list makes the definitive case why brand-name drug companies must stop blocking generic competition", said Allen Goldberg, vice president of communications for the Association of Accessible Medicines.

The Dow companies were listed among dozens of generic and brand-name drugmakers about which complaints have been filed for refusing to provide samples of their products to generic drugmakers wanting to make copies of the brand-name drugs. "The inability of generic companies to purchase the samples they need slows down, or entirely impedes, the generic drug development process - leading to delays in bringing affordable generic alternatives to patients in need". "We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development and approval". Sign up today to get pharma news and updates delivered to your inbox and read on the go. Actelion received eight letters since 2013 about its pulmonary hypertension medications.

Branded companies often base their decisions to restrict access based on what they say are limitations imposed by a so-called limited distribution program or the equally arcane Risk Evaluation and Mitigation Strategy (REMS) program, which is meant to balance the risks and benefits of a given drug.

Celgene accounts for 31 inquiries from companies wanting samples of its blockbuster multiple myeloma drug Revlimid as well as its popular Pomalyst and Thalomid.

Drug companies are free to charge whatever they want for their products. Some of the products in the new list are indeed subject to those program limits - but some aren't at all, the FDA said.

For example, some companies said they couldn't share drugs because they are subject to safety restrictions.

FDA was requested by the Generic-drug companies for assistance in receiving samples of a variety of drugs from those companies, including cancer, HIV and rare disease drugs.

"I'm not looking to shame drug companies", Gottlieb said at a breakfast with reporters Tuesday.

Congress has also looked at legislation to crack down on these tactics. It was dropped from the Bipartisan Budget Act in February under heavy pressure from the brand-name pharmaceutical industry. For those that are, the FDA will review the protocol the generic company proposes to use to protect the tight distribution and write a "safety determination letter" to ensure the original drugmaker that releasing samples won't violate the REMS. Makers of the copycat drugs say that in some cases they've been unable to get samples of the drugs due to safety programs that were created to protect patients, but that have been used instead to prevent competition. Together with Novartis, the former Swiss biotech has the highest number of products - four - that generic competitors have claimed to have trouble accessing.

Share

Advertisement

Related Posts

Google to Ditch Chrome's 'Secure' Badge for HTTPS Pages in September
Since obtaining HTTPS has become much cheaper and easier these days, such changes were bound to take place. The latest development will not affect sites that are now using the HTTP standard.

Russian ex-spy Skripal discharged from hospital
Meanwhile, Britain's Metropolitan Police said that the investigation into the incident was ongoing. Skripal is a retired military officer formerly of the Russian GRU, or military intelligence. "Mr.

Testing Stock Performance of - NXP Semiconductors NV (NASDAQ:NXPI)
On average, analysts expect NXP Semiconductors to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year. Shares of NXP Semiconductors traded down $1.97, reaching $106.87, during midday trading on Thursday, MarketBeat.com reports.

Google One: Google Drive cloud storage gets a new name, cheaper prices
Also, access to extras from other Google products, like credits on Google Play or deals on select hotels found in Google Search. Google hasn't shared what the pricing structure will be for shared plans but we'll be keeping an eye out for updates.

Mourinho, Conte make peace ahead of FA Cup final
United finished second in the Premier League this season, while Chelsea failed to qualify for next season's Champions League . "You don't want to be on the back of losing two FA Cup finals in a row", Fabregas added.

China drops anti-dumping probe of USA sorghum imports
Beijing still threatens to slap aggressive 25 percent tariffs on a swathe of USA farm goods, including sorghum and soybeans. Shipping containers are seen at Nansha terminal of Guangzhou port, in Guangdong province, China, June 14, 2017.

Nokia X6 could be made available outside China
HMD has exclusively made this device available in China and we may see its global launch after all, as reported by GSM Arena . Screen: a notched 5.8-inch FHD+ (2280 x 1080) display , 19:9 aspect ratio 2.5D display , Corning Gorilla Glass 3 protection.

Sharapova too good for Gavrilova in Rome
The walkover means the Romanian will retain the number one ranking if she progresses further in Rome than Dane Caroline Wozniacki. The set finished in 50 minutes with Sharapova showing her poise winning 68 percent from the first serve with 22 winners.

The father of the bride: Thomas Markle
I had to evaluate, even if I had been invited, it would have been a bit hard . "Nonetheless we wish her well, it is what it is". Mr Markle , 73, underwent emergency surgery on Wednesday at a different hospital, according to the celebrity website TMZ .

Penn State versus Pittsburgh to be nationally televised, air in primetime
The Lions are 51-43-4 all-time against the Panthers, including a 33-14 victory previous year in Happy Valley. The Keystone Classic presented by Peoples Natural Gas will kick at 8 p.m. and air on ABC .

© 2015 ExpressNewsline. All Rights reserved.